News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Week In Review: Biotech Ends Q3 With A Bang



10/3/2006 1:53:58 PM

October 1, 2006 – Biotech had a great week, ending the third quarter on a high note and making it the best quarter of the year so far. The Centient Biotech 200™ rose 92 points or 2.5% to close at 3821.43, outperforming the S&P 500 and Nasdaq. Breadth was in line with the rise in the CBT 200™ index, while the action in the IPO market is picking up considerably. The crop of 2006 biotech IPOs had an especially strong week, led by a 312% increase in Acorda, based on positive news about its MS drug. Among the more seasoned biotech issues, GPC climbed following strong results from its prostate cancer drug; VaxGen moved up after solving its reporting problems, BioCryst announced good avian flu news; and Diversa rose after telling its story at an investor conference. More details...



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES